ERN1 and Alzheimer disease: In conclusion, the current study revealed the relevant role of IRE1α-XBP1s signaling pathway in AD formation and progression and proved the therapeutic potential of the IRE1α endoribonuclease domain inhibitor MKC-3946 in AD.